PTX 2.50% 3.9¢ prescient therapeutics limited

Time to shine PTX, page-31

  1. 313 Posts.
    think u were spot on with the 8c CR skara. this is now pre-consolidation 0.4c. Crazy times in anyones language. And all rests on the heads of management. The worst performance by any management in my portolio, and i've got a bunch of penny stocks. I'll be contacting the company with my thoughts on their performance (a consolidation and 6mth pre-notice CR, when the SP was finally gaining some traction/momentum) and a please explain.
    This hasn't changed the technology, although their complete silence on Co-X-gene is concerning. Transgene to announce new pre-clinical data at conference April 20th and working toward PhaseIII clinicals.
    http://www.businesswire.com/news/ho...l-Data-TG4010-Combination-Immune#.VRTp9_mUeSo
    http://www.businesswire.com/news/ho...ncial-Results-Outlines-Promising#.VRTqE_mUeSo

    I know that license prob doesn't hold much $$ for PTX, but interest in the technology for other cancers would surely spike.
    Any, bottom draw as you said skara. Note to self: never invest with the heart, only leads to heartache!
    GLTA SHs.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.001(2.50%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.0¢ 3.9¢ $10.55K 269.2K

Buyers (Bids)

No. Vol. Price($)
7 757841 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 647611 1
View Market Depth
Last trade - 15.30pm 20/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.